The Ministry of Health, Labour and Welfare Japan has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL every four weeks ...
Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold ...
Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...
The findings suggest that symptoms of Alzheimer's are closely linked to the makeup of the gut. Today, evidence strongly ...
A diagnosis in the early stages may allow you to start treatments that can slow disease progression.
“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...
Understanding the link between mental health and Alzheimer's is crucial, as studies show that depression may raise the risk ...
Alzheimer's disease is a progressive brain disorder that affects memory and thinking skills. It is the most common cause of ...
The Lancaster Walk to End Alzheimer's raised more than $137,600 to support the care, support and research programs of the ...
A completely different approach to stopping the progression of Alzheimer's disease pioneered by a research institute based in Westchester County, NY is now being tested nationwide.
Alzheimer’s disease is an illness that affects millions of people worldwide, with the number of people living with dementia across the world expected to increase up to 139 million in 2050, according ...
This past weekend was the annual Walk to End Alzheimer’s in Eagle. Every year, the event is gaining in attendance. We all are ...